82617-49-0

Usage

Uses

Used in Pharmaceutical Industry:
2-bromo-1-bromomethyl-3-nitrobenzene is used as a precursor in the synthesis of various pharmaceuticals for its high reactivity and ability to form a wide range of organic compounds. It plays a crucial role in the development of new drugs and medicines.
Used in Agrochemical Industry:
In the agrochemical industry, 2-bromo-1-bromomethyl-3-nitrobenzene is used as a starting material for the production of various agrochemicals, such as pesticides and herbicides. Its reactivity allows for the creation of effective compounds to protect crops and enhance agricultural productivity.
Used in Dye and Pigment Production:
2-bromo-1-bromomethyl-3-nitrobenzene is used as a building block in the synthesis of dyes and pigments due to its ability to form a variety of organic compounds. Its incorporation into these products contributes to the development of vibrant colors and hues in various applications.
Used in Specialty Chemicals:
As a versatile chemical compound, 2-bromo-1-bromomethyl-3-nitrobenzene is used in the production of specialty chemicals, which have unique properties and applications in different industries. Its reactivity and ability to form diverse organic compounds make it a valuable component in the synthesis of these specialty chemicals.

Upstream product

• 41085-43-2 2-bromo-3-nitrotoluene 
• 34241-39-9 azobisisobutyronitrile 
• 570-24-1 2-Methyl-6-nitroaniline 
• 83141-02-0 2-bromomethyl-1,3-dichloro-4-nitro-benzene 

Downstream Products

• 226895-42-7 2-bromo-3-nitro-1-[(2-propen-1-yloxy)methyl]benzene 
• 851659-44-4 2-bromo-3-nitro-1-[(3-buten-2-yloxy)methyl]benzene 
• 851659-49-9 2-bromo-3-nitro-1-[(2-ethenylphenoxy)methyl]benzene 
• 226895-51-8 dimethyl 2-(2-bromo-3-nitrophenyl)-1,1-ethanedicarboxylate 
• 1268336-13-5 3-nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate 
• 1268336-14-6 7-nitrobenzo[c][1,2]oxaborol-1(3H)-ol 
• 478-89-7 Pyroclavin 
• 569-26-6 festuclavine 
• 436-41-9 (+)-Costaclavine 

Relevant academic research and scientific papers

Organic electroluminescent compound as well as preparation method and application thereof

The invention provides an organic electroluminescent compound as well as a preparation method and application thereof. The organic electroluminescent compound has a structure as shown in a formula I,the organic electroluminescent compound is endowed with

THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR TARGETING TUBULIN, CH-TOG, AURORA A KINASE, TPX2, CDK5RAP2 AND/OR ASPM

The present disclosure relates to compounds, methods and uses thereof for targeting tubulin, ch-TOG, Aurora A kinase, TPX2, Cdk5rap2 and/or ASPM and for the treatment of cancer in a subject. For example, the compounds can comprise compounds of Formula I or a pharmaceutically acceptable salt, solvate or prodrug thereof. A, Z, RA, RB, R1, R2, R3, R4 and R5 can have different values.

THIENOISOQUINOLINES AND THEIR DERIVATIVES FOR THE TREATMENT OF CANCER

The present disclosure relates to fused N-arylsulfonamidyl-thienoisoquinoline compounds, derivatives and pharmaceutical compositions thereof, and methods and uses in inhibiting cancer cell growth, along with a supplemental anti-cancer agent. Centrosome targeting and microtubule depolymerisation are attractive in designing the present chemotherapeutic compounds. The various diseases and conditions treated include various types of cell cancers, and in vitro inhibition.

Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents

A series of boron-containing benzoxaborole compounds was designed and synthesized for a structure-activity relationship investigation surrounding 7-(HOOCCH2CH2)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (1) with the goal of discovering

BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS

This invention provides novel compounds of the following formula useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties

We have synthesized and evaluated a new series of acyclic P4-benzoxaborole-based HCV NS3 protease inhibitors. Structure-activity relationships were investigated, leading to the identification of compounds 5g and 17 with low nanomolar potency in the enzymatic and cell-based replicon assay. The linker-truncated compound 5j was found to exhibit improved absorption and oral bioavailability in rats, suggesting that further reduction of molecular weight and polar surface area could result in improved drug-like properties of this novel series.

Use of novel organoselenium compounds as pro-oxidizing agents their methods of preparation and pharmaceutical compositions and application thereof

Compounds represented by the following formula I: STR1 in which: R1 to R5 can have various meanings of which alkyl, substituted or non-substituted aryl, and m is equal to 0 or 1, X is selected from (CR6 R7)

Insecticidal (1,1'-biphenyl)-3-ylmethyl esters

[1,1'-Biphenyl]-3-ylmethyl pyrethroid esters, as well as processes, uses, and intermediates thereto, are disclosed. The [1,1'-biphenyl]-3-ylmethyl pyrethroid esters control a broad spectrum of insects as well as acarids.

3-(Pyrrol-1-yl)phenylmethyl esters and intermediates

3-(Pyrrol-1-yl)phenylmethyl esters and intermediates having the general formula STR1 the use of the esters as pesticides, compositions thereof and a process for preparation are disclosed and exemplified.